275 related articles for article (PubMed ID: 31450893)
1. The Relationship between the Methylation of Promoter Regions of Tumor Suppressor Genes PTEN and APC with Endometrial Cancer.
Ghazanfari T; Asaadi Tehrani G; Maziri P
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2259-2265. PubMed ID: 31450893
[TBL] [Abstract][Full Text] [Related]
2. High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India.
Kadian LK; Yadav R; Nanda S; Gulshan G; Sharma S; Yadav C
Mol Biol Rep; 2020 Dec; 47(12):9725-9732. PubMed ID: 33230782
[TBL] [Abstract][Full Text] [Related]
3.
Khatami F; Shahriari S; Aminimoghaddam S; Klashami ZN; Farahani MS; Teimoori-Toolabi L; Amoli MM; Asadi M; Rashidi BH
Epigenomics; 2023 Apr; 15(8):507-516. PubMed ID: 37345350
[No Abstract] [Full Text] [Related]
4. Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype.
Zysman M; Saka A; Millar A; Knight J; Chapman W; Bapat B
Cancer Res; 2002 Jul; 62(13):3663-6. PubMed ID: 12097272
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.
Yanokura M; Banno K; Adachi M; Aoki D; Abe K
Int J Oncol; 2017 Jun; 50(6):1934-1946. PubMed ID: 28440489
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of p16 and APC in gastrointestinal cancer patients.
Erdem B; Küçükyıldırım S; Sağlar E; Polat Z; Mergen H
Turk J Gastroenterol; 2014 Oct; 25(5):512-7. PubMed ID: 25417611
[TBL] [Abstract][Full Text] [Related]
8. Considerations when analyzing the methylation status of PTEN tumor suppressor gene.
Zysman MA; Chapman WB; Bapat B
Am J Pathol; 2002 Mar; 160(3):795-800. PubMed ID: 11891178
[TBL] [Abstract][Full Text] [Related]
9. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
10. Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran.
Yari K; Payandeh M; Rahimi Z
Tumour Biol; 2016 Jun; 37(6):8145-52. PubMed ID: 26715274
[TBL] [Abstract][Full Text] [Related]
11. [Pseudogene PTENP1 5'-region methylation in endometrial cancer and hyperplasias].
Kovalenko TF; Sorokina AV; Ozolinia LA; Patrushev LI
Bioorg Khim; 2013; 39(4):445-53. PubMed ID: 24707726
[TBL] [Abstract][Full Text] [Related]
12. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
[TBL] [Abstract][Full Text] [Related]
13. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenström J; Höög A; Larsson C
PLoS One; 2010 Mar; 5(3):e9472. PubMed ID: 20208994
[TBL] [Abstract][Full Text] [Related]
14. APC Promoter Hypermethylation as a Prognostic Marker in Breast Cancer Patients.
Saelee P; Pongtheerat T
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3627-3632. PubMed ID: 33369461
[TBL] [Abstract][Full Text] [Related]
15. Methylation Analysis of BRCA1 and APC in Breast Cancer and It's Relationship to Clinicopathological Features.
Shakeri H; Fakhrjou A; Nikanfar A; Mohaddes-Ardebili SM
Clin Lab; 2016 Dec; 62(12):2333-2337. PubMed ID: 28164568
[TBL] [Abstract][Full Text] [Related]
16. APC promoter hypermethylation is an early event in endometrial tumorigenesis.
Ignatov A; Bischoff J; Ignatov T; Schwarzenau C; Krebs T; Kuester D; Costa SD; Roessner A; Semczuk A; Schneider-Stock R
Cancer Sci; 2010 Feb; 101(2):321-7. PubMed ID: 19900189
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of the association between APC promoter methylation and breast cancer.
He K; Zhang L; Long X
Oncotarget; 2016 Jun; 7(25):37920-37930. PubMed ID: 27191268
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
[TBL] [Abstract][Full Text] [Related]
19. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma.
Salvesen HB; MacDonald N; Ryan A; Jacobs IJ; Lynch ED; Akslen LA; Das S
Int J Cancer; 2001 Jan; 91(1):22-6. PubMed ID: 11149415
[TBL] [Abstract][Full Text] [Related]
20. Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells.
Lubecka-Pietruszewska K; Kaufman-Szymczyk A; Stefanska B; Cebula-Obrzut B; Smolewski P; Fabianowska-Majewska K
Eur J Pharmacol; 2014 Jan; 723():276-87. PubMed ID: 24296317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
